These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30391855)

  • 1. α-Sulfonamidophosphonates as new anti-mycobacterial chemotypes: Design, development of synthetic methodology, and biological evaluation.
    Bhagat S; Supriya M; Pathak S; Sriram D; Chakraborti AK
    Bioorg Chem; 2019 Feb; 82():246-252. PubMed ID: 30391855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship.
    Dhameliya TM; Tiwari R; Banerjee A; Pancholia S; Sriram D; Panda D; Chakraborti AK
    Eur J Med Chem; 2018 Jul; 155():364-380. PubMed ID: 29902722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents.
    Dhameliya TM; Patel KI; Tiwari R; Vagolu SK; Panda D; Sriram D; Chakraborti AK
    Bioorg Chem; 2021 Feb; 107():104538. PubMed ID: 33349456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation.
    Jadhavar PS; Patel KI; Dhameliya TM; Saha N; Vaja MD; Krishna VS; Sriram D; Chakraborti AK
    Bioorg Chem; 2020 Jun; 99():103774. PubMed ID: 32224336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies.
    Pancholia S; Dhameliya TM; Shah P; Jadhavar PS; Sridevi JP; Yogeshwari P; Sriram D; Chakraborti AK
    Eur J Med Chem; 2016 Jun; 116():187-199. PubMed ID: 27061982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids.
    Xu Z; Zhang S; Song X; Qiang M; Lv Z
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
    Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
    Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
    Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
    J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
    Tanwar B; Kumar A; Yogeeswari P; Sriram D; Chakraborti AK
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5960-5966. PubMed ID: 27839684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
    Pieroni M; Lilienkampf A; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Oct; 52(20):6287-96. PubMed ID: 19757815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.
    Ozeki Y; Igarashi M; Doe M; Tamaru A; Kinoshita N; Ogura Y; Iwamoto T; Sawa R; Umekita M; Enany S; Nishiuchi Y; Osada-Oka M; Hayashi T; Niki M; Tateishi Y; Hatano M; Matsumoto S
    PLoS One; 2015; 10(11):e0141658. PubMed ID: 26571296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
    Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
    Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-step synthesis and in vitro anti-mycobacterial activity of novel nitrofurantoin analogues.
    Zuma NH; Smit FJ; Seldon R; Aucamp J; Jordaan A; Warner DF; N'Da DD
    Bioorg Chem; 2020 Mar; 96():103587. PubMed ID: 32044516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
    Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and in vitro anti-mycobacterial activities of homonuclear and heteronuclear bis-isatin derivatives.
    Xu Y; Guan J; Xu Z; Zhao S
    Fitoterapia; 2018 Jun; 127():383-386. PubMed ID: 29631015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Biological Evaluation of Hybrid 1,5- and 2,5-Disubstituted Indoles as Potentially New Antitubercular Agents.
    Soares A; Estevao MS; Marques MMB; Kovalishyn V; Latino DARS; Aires-de-Sousa J; Ramos J; Viveiros M; Martins F
    Med Chem; 2017; 13(5):439-447. PubMed ID: 28185538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of oxime-functionalized nitrofuranylamides as novel antitubercular agents.
    Fan YL; Wu JB; Ke X; Huang ZP
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3064-3066. PubMed ID: 30119957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.